A CRISPR/Cas9-mediated screen identifies determinants of early plasma cell differentiation

Ermeng Xiong1, Oliver Popp2, Claudia Salomon1

  • 1Immune Regulation and Cancer, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.

Frontiers in Immunology
|January 23, 2023
PubMed
Abstract

Related Concept Videos